Extract from Dr Flemings Website www.flemingmethod.com/best-available-published-evidence
How to recover from cvax injuries and counter damage from shedding
CURRENT POTENTIAL TREATMENTS CONSIDERATIONS BASED UPON BEST AVAILABLE EVIDENCE RESEARCH RESULTS - FOCUSING ON SPECIFIC COMPONENTS - FOR PEOPLE WHO HAVE BEEN VACCINATED
Based upon the best available evidence currently being collected, the fundamental goals for treating potential complications from drug vaccine delivery of genetic material, includes first blocking the Nuclear Protein Complex (NPC), to minimize continued entry and re-entry of this genetic material into the cellular nuclear region where reverse transcription (RT) could occur; protecting the native human DNA.
The next step is to remove any circulation spike proteins, minimizing the potential harm they might cause including InflammoThrombotic Response (ITR) disease and Prion diseases. The next logical step would be to interfere with any reuptake of spike protein by host cells that could serve as potential new sources of prions, mRNA or DNA, with potential RT, or any other potential sources of SARS-CoV-2 genetic material or any other genetic or non-genetic material circulating from the injected drug vaccines. The fourth goal is to minimize any potential damage caused by the prion-like domains (PLDs) including reducing the potential longer term neurologic, cardiac, and other organ tissue damage. 5 June 2021 8 This sequence of steps will hopefully reduce the genetic load introduced into the body by these drug vaccines. By interfering with the entry and re-entry of this genetic material through the NPC through this series of steps, this will hopefully provide adequate time for sufficient glycosylase enzyme removal of genetic bases or nucleotide excision - repair mechanisms - of any damaged DNA; through continued encouragement of transcription of the viral – and other – genetic material, increasing the potential for these DNA repairs to occur. In essence, by reducing the active viral or spike protein load through these steps, the increased transcription required for maintenance of the genetic code or protein products, will increase the potential for DNA excision repair and exhaust or at a minimum fatigue the viral genetic load. Step 1: Stop the Reverse Transcriptase (RT) – Block the Nuclear Protein Complex (NPC) (A) Ivermectin 0.2-0.4 mg/kg body weight by mouth (PO) every two weeks. Step 2: Remove Spike Protein in circulation that could cause ITR or prion-like initiated amyloid or equivalent plaquing. (A) Casirivimab 1200 mg & Imdevimab 1200 mg provided intravenously together as a single infusion over a minimum of 60-minutes. Step 3A: Reduce further uptake of Spike protein by cells throughout the body including transmission across the Blood Brain Barrier (BBB). (A) Primaquine 200 mg orally given once – Targets ACE2 receptor. (B) Clindamycin 150 mg orally every 6-hours for 7-days – Targets transmembrane protease serine 2 (TMPRSS2) receptor. (C) Hydroxychloroquine 200 mg orally twice a week – Targets ACE2 receptor. Step 3B: Reduce further translation of mRNA to spike protein. (A) The Primaquine from 3A also inhibits viral protein translation (production of spike protein from mRNA). (B) The Clindamycin from 3A also inhibits viral protein translation; reduces ITR by reducing tissue necrosis factor – alpha (TNF-α) and interleukin-1 beta (IL1β). (C) The Hydroxychloroquine from 3A enhances zinc entry through the zinc ionophore; enhances the production of type 1 interferons, interferes with ribosomal translation of the spike protein, reduces interleukin-6 (IL-6) levels; 5 June 2021 9 increases cellular pH thereby decreasing viral antigen (mRNA or spike protein) major histocompatability complex (MHC) presentation of the spike protein to Β-cells reducing antibody formation and ITR. (D) Zinc 10 mg orally (po) daily. While this may also interfere with the ACE2 receptor, it also interferes with RNA dependent RNA polymerase (RdRP). (E) Ascorbic Acid (Vitamin C) 2000 mg orally (po) daily to reduce ITR. (F) 1,25-dihydroxycholecalciferol (Vitamin D3) 1500 IU orally (po) daily to reduce ITR. Step 4: Address potential amyloid production and neurologic sequlae resulting from prion-like domains on spike protein. (A) Either heparin 5000 units subcutaneously every 12 hours OR Enoxaparin 1mg/kg body weight subcutaneously every 12 hours. AND (B) Aspirin 325 mg tablets (once or twice daily as tolerated), (C) Treat ApoE through dietary and lifestyle factors; HMG CoA-reductase inhibitors or Probucol [An ATP-binding transporter A1 (ABCA1)]. (D) Niacin (Vitamin B3) 15 mg twice daily. FURTHER INFORMATION WILL BE MADE AVAILABLE BASED UPON BEST AVAILABLE EVIDENCE RESEARCH RESULTS.
Je suis vivant /2Learn4Life
P E T I T I O N
Use of images claimed under creative commons or fair use provisions. All copyrights rest with the originators / owners !